Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001705067 | SCV000243569 | likely benign | not provided | 2020-06-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28050010, 26336887, 24631838) |
Genomic Diagnostic Laboratory, |
RCV000203097 | SCV000257719 | uncertain significance | Tuberous sclerosis 2 | 2015-06-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000203097 | SCV000544482 | benign | Tuberous sclerosis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000567626 | SCV000664689 | likely benign | Hereditary cancer-predisposing syndrome | 2018-10-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000203097 | SCV002039680 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000567626 | SCV002533318 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-10 | criteria provided, single submitter | curation | |
Prevention |
RCV004537590 | SCV004730222 | likely benign | TSC2-related disorder | 2023-04-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |